Catharus ustulatus isolate bCatUst1 chromosome 24, bCatUst1.pri.v2, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Turdidae; Catharus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM020359.1.\nAssembly name: bCatUst1.pri.v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2020/12/22. The original whole-genome shotgun project has the\naccession WNMQ00000000.2.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 06-AUG-2020\nAssembly Method :: FALCON v. DX 1.9.0; FALCON-Unzip v.\n 6.0.0.47841; purge_dups github v.\n purge_haplotig (bitbucket v1.0.3+\n 1.Nov.2018); Scaff10x v. 2; Bionano Solve\n v. 3.2.1_04122018; Salsa2 HiC v. 2.2;\n Arrow polishing and gap filling v.\n Smrtlink_6.0.0.47841; Longranger Align v.\n 2.2.2; freebayes v. 1.3.1; gEVAL manual\n curation v. 2020-08-06; VGP assembly\n pipeline v. 1.5\nAssembly Name :: bCatUst1.pri.v2\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 60.58x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Catharus ustulatus Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC117006965, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC117006965 isoform X1
uncharacterized LOC117006965, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC117006965, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC117006965, transcript variant X3
uncharacterized protein LOC117006965 isoform X2
coiled-coil domain-containing protein 81-like, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
coiled-coil domain-containing protein 81-like, transcript variant X2
coiled-coil domain-containing protein 81-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
coiled-coil domain-containing protein 81-like isoform X3
coiled-coil domain-containing protein 81-like, transcript variant X4
coiled-coil domain-containing protein 81-like, transcript variant X3
coiled-coil domain-containing protein 81-like isoform X2
coiled-coil domain-containing protein 81-like isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: coiled-coil domain-containing protein 30
phosphopantothenoylcysteine synthetase, transcript variant X1
phosphopantothenoylcysteine synthetase, transcript variant X3
phosphopantothenoylcysteine synthetase, transcript variant X4
phosphopantothenoylcysteine synthetase, transcript variant X2
phosphopantothenate--cysteine ligase isoform X1
phosphopantothenate--cysteine ligase isoform X2
phosphopantothenate--cysteine ligase isoform X3
zinc finger MYND-type containing 12, transcript variant X1
zinc finger MYND-type containing 12, transcript variant X3
zinc finger MYND domain-containing protein 12 isoform X3
zinc finger MYND domain-containing protein 12 isoform X1
zinc finger MYND-type containing 12, transcript variant X2
zinc finger MYND domain-containing protein 12 isoform X2
solute carrier family 2 member 1, transcript variant X2
solute carrier family 2 member 1, transcript variant X1
solute carrier family 2, facilitated glucose transporter member 1 isoform X2
solute carrier family 2, facilitated glucose transporter member 1 isoform X1
zinc finger protein 362, transcript variant X1
zinc finger protein 362, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
chymotrypsin-like elastase family member 3B
heparan sulfate proteoglycan 2, transcript variant X1
basement membrane-specific heparan sulfate proteoglycan core protein isoform X1
heparan sulfate proteoglycan 2, transcript variant X4
heparan sulfate proteoglycan 2, transcript variant X3
heparan sulfate proteoglycan 2, transcript variant X2
basement membrane-specific heparan sulfate proteoglycan core protein isoform X4
basement membrane-specific heparan sulfate proteoglycan core protein isoform X3
basement membrane-specific heparan sulfate proteoglycan core protein isoform X2
ubiquitin specific peptidase 48, transcript variant X3
ubiquitin specific peptidase 48, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ubiquitin specific peptidase 48, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 48 isoform X1
ubiquitin carboxyl-terminal hydrolase 48 isoform X2
RAP1 GTPase activating protein, transcript variant X4
RAP1 GTPase activating protein, transcript variant X1
RAP1 GTPase activating protein, transcript variant X2
RAP1 GTPase activating protein, transcript variant X3
rap1 GTPase-activating protein 1 isoform X1
rap1 GTPase-activating protein 1 isoform X2
rap1 GTPase-activating protein 1 isoform X3
alkaline phosphatase, biomineralization associated, transcript variant X5
alkaline phosphatase, biomineralization associated, transcript variant X3
alkaline phosphatase, biomineralization associated, transcript variant X6
alkaline phosphatase, biomineralization associated, transcript variant X4
alkaline phosphatase, biomineralization associated, transcript variant X2
alkaline phosphatase, biomineralization associated, transcript variant X1
alkaline phosphatase, tissue-nonspecific isozyme isoform X2
alkaline phosphatase, tissue-nonspecific isozyme isoform X1
alkaline phosphatase, tissue-nonspecific isozyme isoform X3
endothelin converting enzyme 1, transcript variant X3
endothelin-converting enzyme 1 isoform X3
endothelin converting enzyme 1, transcript variant X4
endothelin-converting enzyme 1 isoform X4
endothelin converting enzyme 1, transcript variant X1
endothelin converting enzyme 1, transcript variant X2
endothelin-converting enzyme 1 isoform X1
endothelin-converting enzyme 1 isoform X2
endothelin converting enzyme 1, transcript variant X5
endothelin-converting enzyme 1 isoform X5
eukaryotic translation initiation factor 4 gamma 3, transcript variant X7
eukaryotic translation initiation factor 4 gamma 3, transcript variant X12
eukaryotic translation initiation factor 4 gamma 3, transcript variant X13
eukaryotic translation initiation factor 4 gamma 3, transcript variant X15
eukaryotic translation initiation factor 4 gamma 3, transcript variant X10
eukaryotic translation initiation factor 4 gamma 3, transcript variant X11
eukaryotic translation initiation factor 4 gamma 3, transcript variant X14
eukaryotic translation initiation factor 4 gamma 3, transcript variant X26
eukaryotic translation initiation factor 4 gamma 3, transcript variant X19
eukaryotic translation initiation factor 4 gamma 3, transcript variant X20
eukaryotic translation initiation factor 4 gamma 3, transcript variant X21
eukaryotic translation initiation factor 4 gamma 3, transcript variant X22
eukaryotic translation initiation factor 4 gamma 3, transcript variant X2
eukaryotic translation initiation factor 4 gamma 3, transcript variant X1
eukaryotic translation initiation factor 4 gamma 3, transcript variant X3
eukaryotic translation initiation factor 4 gamma 3, transcript variant X5
eukaryotic translation initiation factor 4 gamma 3, transcript variant X4
eukaryotic translation initiation factor 4 gamma 3, transcript variant X6
eukaryotic translation initiation factor 4 gamma 3 isoform X1
eukaryotic translation initiation factor 4 gamma 3 isoform X2
eukaryotic translation initiation factor 4 gamma 3 isoform X3
eukaryotic translation initiation factor 4 gamma 3 isoform X4
eukaryotic translation initiation factor 4 gamma 3 isoform X5
eukaryotic translation initiation factor 4 gamma 3 isoform X6
eukaryotic translation initiation factor 4 gamma 3, transcript variant X16
eukaryotic translation initiation factor 4 gamma 3, transcript variant X17
eukaryotic translation initiation factor 4 gamma 3, transcript variant X18
eukaryotic translation initiation factor 4 gamma 3, transcript variant X24
eukaryotic translation initiation factor 4 gamma 3, transcript variant X25
eukaryotic translation initiation factor 4 gamma 3, transcript variant X8
eukaryotic translation initiation factor 4 gamma 3, transcript variant X23
eukaryotic translation initiation factor 4 gamma 3, transcript variant X9
eukaryotic translation initiation factor 4 gamma 3 isoform X7
eukaryotic translation initiation factor 4 gamma 3 isoform X8
eukaryotic translation initiation factor 4 gamma 3 isoform X9
eukaryotic translation initiation factor 4 gamma 3 isoform X10
eukaryotic translation initiation factor 4 gamma 3 isoform X11
eukaryotic translation initiation factor 4 gamma 3 isoform X12
eukaryotic translation initiation factor 4 gamma 3 isoform X19
eukaryotic translation initiation factor 4 gamma 3 isoform X13
eukaryotic translation initiation factor 4 gamma 3 isoform X14
eukaryotic translation initiation factor 4 gamma 3 isoform X15
eukaryotic translation initiation factor 4 gamma 3 isoform X17
eukaryotic translation initiation factor 4 gamma 3 isoform X18
eukaryotic translation initiation factor 4 gamma 3 isoform X16
heterochromatin protein 1 binding protein 3, transcript variant X1
heterochromatin protein 1 binding protein 3, transcript variant X2
heterochromatin protein 1-binding protein 3 isoform X1
heterochromatin protein 1-binding protein 3 isoform X2
SH2 domain containing 5, transcript variant X3
SH2 domain containing 5, transcript variant X1
SH2 domain containing 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
SH2 domain containing 5, transcript variant X5
SH2 domain containing 5, transcript variant X2
SH2 domain containing 5, transcript variant X4
SH2 domain-containing protein 5 isoform X1
SH2 domain-containing protein 5 isoform X2
SH2 domain-containing protein 5 isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 4 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 4 codons; deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: kinesin-like protein KIF17
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit
dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit
DNA damage inducible 1 homolog 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
DNA damage inducible 1 homolog 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
DNA damage inducible 1 homolog 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
DNA damage inducible 1 homolog 2, transcript variant X1
pleckstrin homology and RUN domain containing M2, transcript variant X1
pleckstrin homology and RUN domain containing M2, transcript variant X2
pleckstrin homology domain-containing family M member 2 isoform X1
pleckstrin homology domain-containing family M member 2 isoform X2
solute carrier family 25 member 34, transcript variant X3
solute carrier family 25 member 34, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 25 member 34, transcript variant X1
solute carrier family 25 member 34 isoform X1
solute carrier family 25 member 34 isoform X2
transmembrane protein 82, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
transmembrane protein 82, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC117007023, transcript variant X3
uncharacterized LOC117007023, transcript variant X2
uncharacterized LOC117007023, transcript variant X6
uncharacterized LOC117007023, transcript variant X1
uncharacterized LOC117007023, transcript variant X5
uncharacterized LOC117007023, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
spen family transcriptional repressor, transcript variant X1
spen family transcriptional repressor, transcript variant X2
spen family transcriptional repressor, transcript variant X3
spen family transcriptional repressor, transcript variant X4
spen family transcriptional repressor, transcript variant X5
zinc finger and BTB domain containing 17, transcript variant X1
zinc finger and BTB domain containing 17, transcript variant X2
zinc finger and BTB domain-containing protein 17
heat shock protein family B (small) member 7, transcript variant X2
heat shock protein family B (small) member 7, transcript variant X1
chloride voltage-gated channel Ka, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chloride voltage-gated channel Ka, transcript variant X5
chloride voltage-gated channel Ka, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chloride voltage-gated channel Ka, transcript variant X3
chloride voltage-gated channel Ka, transcript variant X6
chloride voltage-gated channel Ka, transcript variant X4
chloride voltage-gated channel Ka, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chloride channel protein ClC-Ka isoform X1
chloride channel protein ClC-Ka isoform X5
chloride channel protein ClC-Ka isoform X2
chloride channel protein ClC-Ka isoform X3
chloride channel protein ClC-Ka isoform X6
chloride channel protein ClC-Ka isoform X4
chloride channel protein ClC-Ka isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ciliogenesis and planar polarity effector 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ciliogenesis and planar polarity effector 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ciliogenesis and planar polarity effector 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ciliogenesis and planar polarity effector 2 isoform X1
ciliogenesis and planar polarity effector 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
SUZ RNA binding domain containing 1, transcript variant X1
SUZ RNA binding domain containing 1, transcript variant X2
SUZ domain-containing protein 1 isoform X1
SUZ domain-containing protein 1 isoform X2
adaptin ear-binding coat-associated protein 2
ciliary rootlet coiled-coil, rootletin, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ciliary rootlet coiled-coil, rootletin, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ciliary rootlet coiled-coil, rootletin, transcript variant X6
ciliary rootlet coiled-coil, rootletin, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ciliary rootlet coiled-coil, rootletin, transcript variant X3
ciliary rootlet coiled-coil, rootletin, transcript variant X2
ATPase cation transporting 13A2, transcript variant X7
ATPase cation transporting 13A2, transcript variant X6
ATPase cation transporting 13A2, transcript variant X5
ATPase cation transporting 13A2, transcript variant X4
ATPase cation transporting 13A2, transcript variant X2
ATPase cation transporting 13A2, transcript variant X3
ATPase cation transporting 13A2, transcript variant X1
polyamine-transporting ATPase 13A2 isoform X7
polyamine-transporting ATPase 13A2 isoform X6
polyamine-transporting ATPase 13A2 isoform X5
polyamine-transporting ATPase 13A2 isoform X4
polyamine-transporting ATPase 13A2 isoform X2
polyamine-transporting ATPase 13A2 isoform X3
polyamine-transporting ATPase 13A2 isoform X1
succinate dehydrogenase complex iron sulfur subunit B
succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
protein-arginine deiminase type-3-like, transcript variant X2
protein-arginine deiminase type-3-like, transcript variant X1
protein-arginine deiminase type-3-like isoform X1
protein-arginine deiminase type-3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Rho guanine nucleotide exchange factor 10 like, transcript variant X1
Rho guanine nucleotide exchange factor 10 like, transcript variant X2
Rho guanine nucleotide exchange factor 10 like, transcript variant X3
Rho guanine nucleotide exchange factor 10 like, transcript variant X4
rho guanine nucleotide exchange factor 10-like protein isoform X1
rho guanine nucleotide exchange factor 10-like protein isoform X2
rho guanine nucleotide exchange factor 10-like protein isoform X3
rho guanine nucleotide exchange factor 10-like protein isoform X4
Rho guanine nucleotide exchange factor 10 like, transcript variant X5
rho guanine nucleotide exchange factor 10-like protein isoform X5
Rho guanine nucleotide exchange factor 10 like, transcript variant X6
rho guanine nucleotide exchange factor 10-like protein isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
aldehyde dehydrogenase 4 family member A1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X2
ubiquitin protein ligase E3 component n-recognin 4, transcript variant X1
E3 ubiquitin-protein ligase UBR4 isoform X2
E3 ubiquitin-protein ligase UBR4 isoform X1
ER membrane protein complex subunit 1, transcript variant X2
ER membrane protein complex subunit 1, transcript variant X1
ER membrane protein complex subunit 1 isoform X2
ER membrane protein complex subunit 1 isoform X1
MRT4 homolog, ribosome maturation factor
aflatoxin B1 aldehyde reductase member 2
lysosomal amino acid transporter 1 homolog
capping actin protein of muscle Z-line subunit beta, transcript variant X2
F-actin-capping protein subunit beta isoform X2
capping actin protein of muscle Z-line subunit beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
F-actin-capping protein subunit beta isoform X1
mitochondrial contact site and cristae organizing system subunit 10
neuroblastoma suppressor of tumorigenicity 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transmembrane and coiled-coil domain-containing protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
group IIE secretory phospholipase A2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
phospholipase A2, membrane associated-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77% coverage of the annotated genomic feature by RNAseq alignments
phospholipase A2 nigroviriditoxin basic subunit B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
von Willebrand factor A domain containing 5B1, transcript variant X1
von Willebrand factor A domain containing 5B1, transcript variant X3
von Willebrand factor A domain containing 5B1, transcript variant X6
von Willebrand factor A domain containing 5B1, transcript variant X5
von Willebrand factor A domain containing 5B1, transcript variant X7
von Willebrand factor A domain containing 5B1, transcript variant X8
von Willebrand factor A domain-containing protein 5B1 isoform X1
von Willebrand factor A domain-containing protein 5B1 isoform X3
von Willebrand factor A domain-containing protein 5B1 isoform X6
von Willebrand factor A domain-containing protein 5B1 isoform X5
von Willebrand factor A domain-containing protein 5B1 isoform X7
von Willebrand factor A domain-containing protein 5B1 isoform X8
von Willebrand factor A domain containing 5B1, transcript variant X4
von Willebrand factor A domain-containing protein 5B1 isoform X4
von Willebrand factor A domain containing 5B1, transcript variant X2
von Willebrand factor A domain-containing protein 5B1 isoform X2
calcium/calmodulin dependent protein kinase II inhibitor 1
calcium/calmodulin-dependent protein kinase II inhibitor 1
mitochondrial E3 ubiquitin protein ligase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mitochondrial ubiquitin ligase activator of NFKB 1
family with sequence similarity 43 member B
cytidine deaminase, transcript variant X3
cytidine deaminase, transcript variant X1
cytidine deaminase, transcript variant X4
cytidine deaminase, transcript variant X7
cytidine deaminase, transcript variant X6
cytidine deaminase, transcript variant X2
cytidine deaminase, transcript variant X5
serine/threonine-protein kinase PINK1, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: agmatinase, mitochondrial
DnaJ heat shock protein family (Hsp40) member C16
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dnaJ homolog subfamily C member 16
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: chymotrypsin-C-like
chymotrypsin-C-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chymotrypsin-C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
EF-hand domain family member D2, transcript variant X1
EF-hand domain family member D2, transcript variant X2
EF-hand domain-containing protein D2 isoform X1
EF-hand domain-containing protein D2 isoform X2
forkhead associated phosphopeptide binding domain 1
forkhead-associated domain-containing protein 1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
complement C1q A chain, transcript variant X2
complement C1q A chain, transcript variant X1
uncharacterized LOC117006754, transcript variant X1
uncharacterized LOC117006754, transcript variant X2
Wnt family member 4, transcript variant X1
Wnt family member 4, transcript variant X2
cell division cycle 42, transcript variant X2
cell division control protein 42 homolog isoform X2
cell division cycle 42, transcript variant X1
cell division control protein 42 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Y-box binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 187 ESTs, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Y-box binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 147 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
homeodomain interacting protein kinase 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
homeodomain-interacting protein kinase 4
mechanistic target of rapamycin kinase, transcript variant X2
mechanistic target of rapamycin kinase, transcript variant X1
serine/threonine-protein kinase mTOR isoform X2
serine/threonine-protein kinase mTOR isoform X1
angiopoietin like 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
angiopoietin like 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
angiopoietin-related protein 7 isoform X1
angiopoietin-related protein 7 isoform X2
UbiA prenyltransferase domain containing 1, transcript variant X1
UbiA prenyltransferase domain containing 1, transcript variant X2
ubiA prenyltransferase domain-containing protein 1 isoform X2
ubiA prenyltransferase domain-containing protein 1 isoform X1
dispatched RND transporter family member 3, transcript variant X3
dispatched RND transporter family member 3, transcript variant X4
dispatched RND transporter family member 3, transcript variant X1
dispatched RND transporter family member 3, transcript variant X2
mitotic arrest deficient 2 like 2, transcript variant X2
mitotic arrest deficient 2 like 2, transcript variant X1
mitotic arrest deficient 2 like 2, transcript variant X3
mitotic spindle assembly checkpoint protein MAD2B
angiotensin II receptor associated protein
type-1 angiotensin II receptor-associated protein
uncharacterized protein C1orf167 homolog
methylenetetrahydrofolate reductase, transcript variant X2
methylenetetrahydrofolate reductase, transcript variant X1
methylenetetrahydrofolate reductase, transcript variant X3
methylenetetrahydrofolate reductase isoform X1
methylenetetrahydrofolate reductase isoform X2
guanylate cyclase soluble subunit beta-2-like
chymotrypsin-like elastase family member 2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
KIAA2013 ortholog, transcript variant X2
KIAA2013 ortholog, transcript variant X1
uncharacterized protein KIAA2013 homolog
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1
migration and invasion inhibitory protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
migration and invasion-inhibitory protein
TNF receptor superfamily member 8, transcript variant X3
TNF receptor superfamily member 8, transcript variant X4
TNF receptor superfamily member 8, transcript variant X2
TNF receptor superfamily member 8, transcript variant X1
TNF receptor superfamily member 8, transcript variant X6
TNF receptor superfamily member 8, transcript variant X5
TNF receptor superfamily member 8, transcript variant X7
tumor necrosis factor receptor superfamily member 8 isoform X1
tumor necrosis factor receptor superfamily member 8 isoform X2
tumor necrosis factor receptor superfamily member 8 isoform X3
tumor necrosis factor receptor superfamily member 8 isoform X4
TNF receptor superfamily member 8, transcript variant X8
tumor necrosis factor receptor superfamily member 8 isoform X5
tumor necrosis factor receptor superfamily member 1B
vacuolar protein sorting 13 homolog D, transcript variant X1
vacuolar protein sorting 13 homolog D, transcript variant X3
vacuolar protein sorting 13 homolog D, transcript variant X2
vacuolar protein sorting 13 homolog D, transcript variant X4
vacuolar protein sorting-associated protein 13D isoform X1
vacuolar protein sorting-associated protein 13D isoform X3
vacuolar protein sorting-associated protein 13D isoform X2
vacuolar protein sorting-associated protein 13D isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat-containing protein 38-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
PR domain zinc finger protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PR domain zinc finger protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PR domain zinc finger protein 2-like isoform X2
PR domain zinc finger protein 2-like isoform X1
uncharacterized LOC117006791, transcript variant X1
uncharacterized LOC117006791, transcript variant X2
28S ribosomal protein S16, mitochondrial-like
proton-associated sugar transporter A-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
proton-associated sugar transporter A-like isoform X2
proton-associated sugar transporter A-like, transcript variant X4
proton-associated sugar transporter A-like, transcript variant X3
proton-associated sugar transporter A-like, transcript variant X1
proton-associated sugar transporter A-like, transcript variant X2
proton-associated sugar transporter A-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PR domain zinc finger protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC117006779, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC117006779, transcript variant X1
uncharacterized LOC117006779, transcript variant X5
uncharacterized LOC117006779, transcript variant X4
uncharacterized LOC117006779, transcript variant X3
uncharacterized protein LOC117006779 isoform X2
uncharacterized protein LOC117006779 isoform X1
uncharacterized protein LOC117006779 isoform X5
uncharacterized protein LOC117006779 isoform X4
uncharacterized protein LOC117006779 isoform X3
uncharacterized LOC117006792, transcript variant X2
uncharacterized LOC117006792, transcript variant X1
solute carrier family 45 member 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
proton-associated sugar transporter A isoform X2
solute carrier family 45 member 1, transcript variant X3
solute carrier family 45 member 1, transcript variant X4
solute carrier family 45 member 1, transcript variant X2
solute carrier family 45 member 1, transcript variant X1
proton-associated sugar transporter A isoform X1
solute carrier family 45 member 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
proton-associated sugar transporter A isoform X3
ERBB receptor feedback inhibitor 1, transcript variant X2
ERBB receptor feedback inhibitor 1, transcript variant X3
ERBB receptor feedback inhibitor 1, transcript variant X1
tumor necrosis factor receptor superfamily member 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
period circadian regulator 3, transcript variant X4
period circadian regulator 3, transcript variant X3
period circadian regulator 3, transcript variant X2
period circadian regulator 3, transcript variant X1
period circadian protein homolog 3 isoform X4
period circadian protein homolog 3 isoform X3
period circadian protein homolog 3 isoform X2
period circadian protein homolog 3 isoform X1
period circadian regulator 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
period circadian regulator 3, transcript variant X6
period circadian protein homolog 3 isoform X5
calmodulin binding transcription activator 1, transcript variant X7
calmodulin binding transcription activator 1, transcript variant X3
calmodulin binding transcription activator 1, transcript variant X2
calmodulin binding transcription activator 1, transcript variant X1
calmodulin binding transcription activator 1, transcript variant X5
calmodulin binding transcription activator 1, transcript variant X6
calmodulin binding transcription activator 1, transcript variant X4
calmodulin binding transcription activator 1, transcript variant X8
calmodulin binding transcription activator 1, transcript variant X9
calmodulin binding transcription activator 1, transcript variant X10
calmodulin-binding transcription activator 1 isoform X7
calmodulin-binding transcription activator 1 isoform X3
calmodulin-binding transcription activator 1 isoform X5
calmodulin-binding transcription activator 1 isoform X2
calmodulin-binding transcription activator 1 isoform X1
calmodulin-binding transcription activator 1 isoform X4
calmodulin-binding transcription activator 1 isoform X8
calmodulin-binding transcription activator 1 isoform X9
calmodulin-binding transcription activator 1 isoform X10
calmodulin-binding transcription activator 1 isoform X6
DnaJ heat shock protein family (Hsp40) member C11
zinc finger and BTB domain containing 48
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
pleckstrin homology and RhoGEF domain containing G5, transcript variant X2
pleckstrin homology domain-containing family G member 5 isoform X2
pleckstrin homology and RhoGEF domain containing G5, transcript variant X3
pleckstrin homology and RhoGEF domain containing G5, transcript variant X1
pleckstrin homology domain-containing family G member 5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 25
acyl-CoA thioesterase 7, transcript variant X1
cytosolic acyl coenzyme A thioester hydrolase isoform X1
acyl-CoA thioesterase 7, transcript variant X2
cytosolic acyl coenzyme A thioester hydrolase isoform X2
isoprenylcysteine carboxyl methyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protein-S-isoprenylcysteine O-methyltransferase
chromodomain helicase DNA binding protein 5, transcript variant X1
chromodomain helicase DNA binding protein 5, transcript variant X3
chromodomain helicase DNA binding protein 5, transcript variant X2
chromodomain-helicase-DNA-binding protein 5 isoform X1
chromodomain-helicase-DNA-binding protein 5 isoform X3
chromodomain-helicase-DNA-binding protein 5 isoform X2
chromodomain helicase DNA binding protein 5, transcript variant X4
chromodomain-helicase-DNA-binding protein 5 isoform X4
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X4
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X5
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X3
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X2
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X1
voltage-gated potassium channel subunit beta-2 isoform X4
voltage-gated potassium channel subunit beta-2 isoform X3
voltage-gated potassium channel subunit beta-2 isoform X2
voltage-gated potassium channel subunit beta-2 isoform X1
uncharacterized LOC117006748, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC117006748, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
DNA fragmentation factor subunit beta, transcript variant X2
DNA fragmentation factor subunit beta, transcript variant X1
DNA fragmentation factor subunit beta isoform X2
DNA fragmentation factor subunit beta isoform X1
centrosomal protein 104, transcript variant X1
centrosomal protein 104, transcript variant X2
leucine-rich repeat-containing protein 47
coiled-coil domain-containing protein 27
myo-inositol 2-dehydrogenase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inositol 2-dehydrogenase-like isoform X1
myo-inositol 2-dehydrogenase-like, transcript variant X2
myo-inositol 2-dehydrogenase-like isoform X2
tumor protein p73, transcript variant X1
tumor protein p73, transcript variant X4
tumor protein p73, transcript variant X2
tumor protein p73, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tumor protein p63-regulated gene 1-like protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: multiple epidermal growth factor-like domains protein 6
Rho guanine nucleotide exchange factor 16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
histone-lysine N-methyltransferase PRDM16 isoform X1
histone-lysine N-methyltransferase PRDM16 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
histone-lysine N-methyltransferase PRDM16 isoform X2
membrane metalloendopeptidase like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
membrane metalloendopeptidase like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
membrane metallo-endopeptidase-like 1 isoform X1
membrane metallo-endopeptidase-like 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
probable glutamate receptor, transcript variant X2
probable glutamate receptor, transcript variant X1
phospholipase C eta 2, transcript variant X5
phospholipase C eta 2, transcript variant X1
phospholipase C eta 2, transcript variant X2
phospholipase C eta 2, transcript variant X4
phospholipase C eta 2, transcript variant X3
phospholipase C eta 2, transcript variant X6
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X4
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X5
phospholipase C eta 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phospholipase C eta 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phospholipase C eta 2, transcript variant X8
phospholipase C eta 2, transcript variant X11
phospholipase C eta 2, transcript variant X9
phospholipase C eta 2, transcript variant X7
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X7
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X6
phospholipase C eta 2, transcript variant X13
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X8
LOW QUALITY PROTEIN: peroxisome biogenesis factor 10
retention in endoplasmic reticulum sorting receptor 1
SKI proto-oncogene, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
SKI proto-oncogene, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Fanconi anemia core complex-associated protein 20
protein kinase C zeta, transcript variant X1
protein kinase C zeta, transcript variant X2
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X2
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X3
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X1
gamma-aminobutyric acid receptor subunit delta isoform X2
gamma-aminobutyric acid receptor subunit delta isoform X1
cilia and flagella associated protein 74
cilia- and flagella-associated protein 74
transmembrane protein 52, transcript variant X2
transmembrane protein 52, transcript variant X1
uncharacterized LOC117006980, transcript variant X2
uncharacterized LOC117006980, transcript variant X3
uncharacterized LOC117006980, transcript variant X1
G protein subunit beta 1, transcript variant X5
G protein subunit beta 1, transcript variant X3
G protein subunit beta 1, transcript variant X7
G protein subunit beta 1, transcript variant X4
G protein subunit beta 1, transcript variant X1
G protein subunit beta 1, transcript variant X2
G protein subunit beta 1, transcript variant X6
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
solute carrier family 35 member E2A-like, transcript variant X1
solute carrier family 35 member E2A-like, transcript variant X3
solute carrier family 35 member E2A-like, transcript variant X2
solute carrier family 35 member E2A-like
cyclin-dependent kinase 11B, transcript variant X2
cyclin-dependent kinase 11B, transcript variant X1
cyclin-dependent kinase 11B, transcript variant X4
cyclin-dependent kinase 11B, transcript variant X3
cyclin-dependent kinase 11B, transcript variant X5
cyclin-dependent kinase 11B, transcript variant X6
cyclin-dependent kinase 11B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
MIB E3 ubiquitin protein ligase 2, transcript variant X2
MIB E3 ubiquitin protein ligase 2, transcript variant X1
E3 ubiquitin-protein ligase MIB2 isoform X2
E3 ubiquitin-protein ligase MIB2 isoform X1
Golgi integral membrane protein 4-like, transcript variant X4
Golgi integral membrane protein 4-like, transcript variant X2
Golgi integral membrane protein 4-like, transcript variant X1
Golgi integral membrane protein 4-like, transcript variant X3
Golgi integral membrane protein 4-like isoform X1
Golgi integral membrane protein 4-like isoform X2
Golgi integral membrane protein 4-like isoform X3
Golgi integral membrane protein 4-like isoform X4
fibronectin type III domain containing 10
fibronectin type III domain-containing protein 10
SSU72 homolog, RNA polymerase II CTD phosphatase
RNA polymerase II subunit A C-terminal domain phosphatase SSU72
transmembrane protein 240, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane protein 240, transcript variant X2
transmembrane protein 240, transcript variant X3
transmembrane protein 240, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
developmental and secondary metabolism regulator VEL1-like, transcript variant X1
developmental and secondary metabolism regulator VEL1-like, transcript variant X2
developmental and secondary metabolism regulator VEL1-like isoform X1
uncharacterized protein LOC117006985 isoform X2
ATPase family AAA domain-containing protein 3
von Willebrand factor A domain containing 1
von Willebrand factor A domain-containing protein 1
uncharacterized LOC117006904, transcript variant X2
uncharacterized LOC117006904, transcript variant X1
39S ribosomal protein L20, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 13 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 13 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
aurora kinase A interacting protein 1, transcript variant X1
aurora kinase A interacting protein 1, transcript variant X2
uncharacterized LOC117006821, transcript variant X2
uncharacterized LOC117006821, transcript variant X1
uncharacterized LOC117006821, transcript variant X3
dishevelled segment polarity protein 1, transcript variant X1
dishevelled segment polarity protein 1, transcript variant X2
dishevelled segment polarity protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
segment polarity protein dishevelled homolog DVL-1 isoform X1
segment polarity protein dishevelled homolog DVL-1 isoform X2
segment polarity protein dishevelled homolog DVL-1 isoform X3
uracil nucleotide/cysteinyl leukotriene receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pseudouridine synthase like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pseudouridine synthase like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pseudouridine synthase like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
tRNA pseudouridine synthase-like 1 isoform X1
tRNA pseudouridine synthase-like 1 isoform X2
pseudouridine synthase like 1, transcript variant X4
tRNA pseudouridine synthase-like 1 isoform X3
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X1
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X2
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X3
uncharacterized LOC117006814, transcript variant X3
uncharacterized LOC117006814, transcript variant X2
uncharacterized LOC117006814, transcript variant X1
sodium channel epithelial 1 subunit delta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
amiloride-sensitive sodium channel subunit delta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
stromal cell derived factor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
stromal cell derived factor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 72% coverage of the annotated genomic feature by RNAseq alignments
tumor necrosis factor receptor superfamily member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
tumor necrosis factor receptor superfamily member 18
chromosome 24 C1orf159 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
chromosome 24 C1orf159 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromosome 24 C1orf159 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein C1orf159 homolog isoform X1
uncharacterized protein C1orf159 homolog isoform X3
uncharacterized protein C1orf159 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC117006900, transcript variant X2
uncharacterized LOC117006900, transcript variant X1
uncharacterized protein LOC117006900 isoform X2
uncharacterized protein LOC117006900 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 5 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 5 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
hes family bHLH transcription factor 4, transcript variant X1
hes family bHLH transcription factor 4, transcript variant X2
PPARGC1 and ESRR induced regulator, muscle 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
PGC-1 and ERR-induced regulator in muscle protein 1
pleckstrin homology domain containing N1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
pleckstrin homology domain-containing family N member 1
kelch like family member 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
kelch like family member 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
kelch like family member 17, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
NOC2 like nucleolar associated transcriptional repressor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
NOC2 like nucleolar associated transcriptional repressor, transcript variant X2
nucleolar complex protein 2 homolog isoform X1
nucleolar complex protein 2 homolog isoform X2
sterile alpha motif domain containing 11, transcript variant X4
sterile alpha motif domain containing 11, transcript variant X5
sterile alpha motif domain containing 11, transcript variant X1
sterile alpha motif domain containing 11, transcript variant X3
sterile alpha motif domain containing 11, transcript variant X2
sterile alpha motif domain containing 11, transcript variant X7
sterile alpha motif domain containing 11, transcript variant X6
sterile alpha motif domain-containing protein 11 isoform X2
sterile alpha motif domain-containing protein 11 isoform X1
sterile alpha motif domain-containing protein 11 isoform X4
sterile alpha motif domain-containing protein 11 isoform X3
arginine-glutamic acid dipeptide repeats, transcript variant X4
arginine-glutamic acid dipeptide repeats, transcript variant X3
arginine-glutamic acid dipeptide repeats, transcript variant X1
arginine-glutamic acid dipeptide repeats, transcript variant X2
arginine-glutamic acid dipeptide repeats, transcript variant X5
arginine-glutamic acid dipeptide repeats protein isoform X3
arginine-glutamic acid dipeptide repeats protein isoform X2
arginine-glutamic acid dipeptide repeats protein isoform X1
arginine-glutamic acid dipeptide repeats protein isoform X4
carbonic anhydrase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
carbonic anhydrase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 5-like, transcript variant X2
solute carrier family 2, facilitated glucose transporter member 5-like, transcript variant X1
solute carrier family 2, facilitated glucose transporter member 5-like isoform X1
solute carrier family 2, facilitated glucose transporter member 5-like isoform X2
G protein-coupled receptor 157, transcript variant X3
G protein-coupled receptor 157, transcript variant X1
G protein-coupled receptor 157, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
G-protein coupled receptor 157 isoform X2
G-protein coupled receptor 157 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63% coverage of the annotated genomic feature by RNAseq alignments
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, transcript variant X3
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, transcript variant X2
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, transcript variant X1
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, transcript variant X4
GDH/6PGL endoplasmic bifunctional protein
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
SPRY domain-containing SOCS box protein 1
transmembrane protein 201, transcript variant X1
transmembrane protein 201, transcript variant X2
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta, transcript variant X1
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X2
leucine zipper and CTNNBIP1 domain containing, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
leucine zipper and CTNNBIP1 domain containing, transcript variant X2
leucine zipper and CTNNBIP1 domain containing, transcript variant X1
nicotinamide nucleotide adenylyltransferase 1
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1
kinesin family member 1B, transcript variant X9
kinesin family member 1B, transcript variant X1
kinesin family member 1B, transcript variant X7
kinesin family member 1B, transcript variant X4
kinesin family member 1B, transcript variant X3
kinesin family member 1B, transcript variant X5
kinesin family member 1B, transcript variant X2
kinesin family member 1B, transcript variant X6
kinesin family member 1B, transcript variant X8
phosphogluconate dehydrogenase, transcript variant X2
6-phosphogluconate dehydrogenase, decarboxylating isoform X2
phosphogluconate dehydrogenase, transcript variant X1
6-phosphogluconate dehydrogenase, decarboxylating isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC117006949, transcript variant X3
uncharacterized LOC117006949, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC117006949, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC117007011, transcript variant X2
uncharacterized LOC117007011, transcript variant X3
uncharacterized LOC117007011, transcript variant X1
uncharacterized LOC117007011, transcript variant X4